TAD-0000032

N/A

Report date: 2025/06/11 11:24:00
NME

Base Information

Drug NameTAD-0000032
Drug Alias NameTAD-0000032TAD-32
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 inhibitorsNeuroprotectants
TargetsPhosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesLgenia IncIndiana University School Of Medicine
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A